Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Sherpa Venture Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 55
Average round size
info
The average size of a deal this fund participated in
$37M
Portfolio companies 42
Rounds per year 13.75
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.24
Key employees 2
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical
Summary

In 2018 was created Sherpa Venture Capital, which is appeared as VC. The venture was found in Asia in China. The leading representative office of defined VC is situated in the Beijing.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical Device, Clinical Trials. Among the most popular portfolio startups of the fund, we may highlight EpimAb Biotherapeutics, Singleron Biotechnologies, Immunochina. The fund has exact preference in a number of founders of portfolio startups.

The fund is constantly included in 7-12 investment rounds annually. Considering the real fund results, this VC is 60 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2019.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Sherpa Venture Capital, startups are often financed by Trend Investment Group, Thiel Capital, ShengJing360. The meaningful sponsors for the fund in investment in the same round are Legend Capital, Hillhouse Capital Group, WuXi AppTec.

We also calculated 2 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sherpa Venture Capital:
Typical Co-investors
Sherpa Venture Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sherpa Venture Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
3taps California, San Francisco, United States
DOTCOM Ventures -
Edison Electric Institute District of Columbia, United States, Washington
Escala Partners Australia, Melbourne, Victoria
Founders & Fools Norway, Oslo
Great Wall Motors China, Hebei, Hebei
Huaxin Lianzhong Touzi Beijing, Beijing, China
Shining Capital China, Hong Kong, Hong Kong Island
Sichuan Hongbo Equity Investment Fund Management China, Gansu, Sichuan
Sparks Capital -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Neukio Biotherapeutics

Biotechnology
$50M02 Sep 2022 Shanghai, Shanghai, China

Fountain Medical Development

Biotechnology
Consulting
Health Care
$150M04 Jul 2022 New York, New York, United States

Yuanyin Bio

Biopharma
Biotechnology
Medical
Pharmaceutical
$43M20 Jun 2022 Haidian, Beijing, China

Raykol

Biotechnology
Chemical
Industrial Automation
$15M14 Jun 2022 Xiamen, China

Starna Therapeutics

Biotechnology
Therapeutics
$23M16 May 2022 Suzhou, Jiangsu, China

Hui-Gene Therapeutics

Biotechnology
Genetics
Life Science
Therapeutics
12 May 2022 Shanghai, China

Shenji Bio

$46M11 Apr 2022 Nanjing, Jiangsu, China

Yuesai Biotechnology

$30M14 Mar 2022 Pudong, Shandong, China

Pilot Biotechnology

Biopharma
Biotechnology
Health Care
Manufacturing
Medical
Pet
16 Dec 2021 Suzhou, Jiangsu, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sherpa Venture Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: